Sumatriptan succinate and Mupirocin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan succinate (sumatriptan succinate) and Mupirocin (mupirocin). Common drug interactions include fatigue among females and malaise among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan succinate and Mupirocin. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.

What is Mupirocin?

Mupirocin has active ingredients of mupirocin. It is often used in impetigo. eHealthMe is studying from 5,940 Mupirocin users. Check the latest studies of Mupirocin.



On Jul, 10, 2026

28 people who take Sumatriptan succinate and Mupirocin together, and have interactions are studied.

Sumatriptan succinate and Mupirocin drug interactions.

What are the common drug interactions of Sumatriptan Succinate and Mupirocin, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Chest discomfort
  3. Colitis (inflammation of colon)
  4. Colitis ulcerative (inflammation of colon with ulcer)
  5. Decreased appetite
  6. Diarrhoea
  7. Dizziness
  8. Ear infection
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Pyrexia (fever)

male:

  1. Malaise (a feeling of general discomfort or uneasiness)

What are the common drug interactions of Sumatriptan Succinate and Mupirocin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Gallbladder disorder
  2. Pyelonephritis (inflammation of kidney caused by bacteria)
  3. Pain
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Cholecystitis chronic (long lasting infection of gallbladder)

40-49:

  1. Fatigue (feeling of tiredness)
  2. Pyrexia (fever)
  3. Nausea (feeling of having an urge to vomit)
  4. Oropharyngeal pain
  5. Rash
  6. Chest discomfort
  7. Chills (felling of cold)
  8. Dizziness
  9. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  10. Fall

50-59:

  1. Abdominal pain upper
  2. Anaemia (lack of blood)
  3. Anal fissure
  4. Arthralgia (joint pain)
  5. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  6. Erythema nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Mastication disorder (disease of chewing food)
  9. Poor venous access
  10. Proctalgia (pain in the rectum)

60+:

  1. Back pain
  2. Infusion related reaction
  3. Diarrhoea
  4. Ear infection
  5. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  6. Nausea (feeling of having an urge to vomit)
  7. Swollen tongue (swelling of tongue)
  8. Influenza
  9. Lymph node pain
  10. Lymphadenopathy (disease or enlargement of lymph nodes)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 8 people, 28.57%
  2. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 7.14%
  3. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 2 people, 7.14%
  4. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 7.14%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 7.14%
  6. Immune System Disorder: 2 people, 7.14%
  7. Hypergammaglobulinaemia (elevated levels of gamma globulin): 2 people, 7.14%
  8. Drowsiness: 2 people, 7.14%
  9. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 7.14%
  10. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan succinate and Mupirocin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sumatriptan succinate and Mupirocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mupirocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mupirocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and mupirocin (the active ingredients of Sumatriptan succinate and Mupirocin, respectively), and Sumatriptan succinate and Mupirocin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: